EU MDR & FDA Phased Plans

For digital health and medical device teams, expanding from the UK into EU or US markets can quickly become a maze of overlapping cybersecurity evidence requirements, regulatory expectations, and procurement questions. The good news is that much of your UK evidence pack can be reused, provided you know where DTAC, EU MDR and FDA 510(k) requirements align and where they diverge. Download our Access to Markets: Key Differences and Overlaps guide to understand what evidence to prepare, where rework can be avoided and how to build a stronger, more efficient route to market.